Chul‐Ho Lee
Impact in
- Pharmacology top 0.5%
- Molecular Biology top 2%
- Metabolism, Diabetes, and Cancer
- Genomics, phytochemicals, and oxidative stress
- Gut microbiota and health
Papers in
- Pharmacology 23
- Co-authors
- Don‐Kyu KimJung‐Ran NohYong‐Hoon KimJung Hwan HwangKyoung‐Shim KimHueng-Sik ChoiYong Deuk KimIn‐Kyu Lee
- Journals
- Journal of Biological Chemistry (11 papers)Diabetes (10 papers)Experimental & Molecular Medicine (6 papers)Archives of Toxicology (6 papers)PLoS ONE (6 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Chul‐Ho Lee
223 papers receiving 7.1k citations
Peers
Comparison fields: 5 of 146
- Pharmacology 451
- Molecular Biology 3.3k
- Toxicology 154
- Endocrinology, Diabetes and Metabolism 702
- Cancer Research 625
Countries citing papers authored by Chul‐Ho Lee
This map shows the geographic impact of Chul‐Ho Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul‐Ho Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul‐Ho Lee more than expected).
Fields of papers citing papers by Chul‐Ho Lee
This network shows the impact of papers produced by Chul‐Ho Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul‐Ho Lee. The network helps show where Chul‐Ho Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Chul‐Ho Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 10 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 23 | |
| 8 | 2015 | 106 | |
| 9 | 2012 | 64 | |
| 10 | 2008 | 15 | |
| 11 | 2007 | 111 | |
| 12 | 2006 | 34 | |
| 13 | [Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer]. | 2005 | 26 |
| 14 | Fluorescence labeled cardiomyocytes derived from embryonic stem cells | 2005 | 2 |
| 15 | CTLA-4 Polymorphism in Myasthenia Gravis | 2004 | 1 |
| 16 | 2002 | 9 | |
| 17 | Urinary 1-Hydroxypyrene and 2-Naphthol as a Biological Exposure Markers of Total Suspended Particulate in the General Population | 2000 | 5 |
| 18 | Pathological Observation of FGS/NgaKist Mice with Glomerulosclerosis | 1996 | 1 |
| 19 | Evaluation of nonleaky C.B-17 SCID mice by ELISA | 1996 | 1 |
| 20 | Batch Scale Storage of Sprouting Foods by Irradiation Combined with Natural Low Temperature - II. Suitability for Potato Chip Processing of Irradiated Potatoes after Storage - | 1982 | 3 |
About Chul‐Ho Lee
Chul‐Ho Lee is a scholar working on Pharmacology, Toxicology, Physiology, Immunology and Biochemistry, having authored 225 papers that have together received 7.2k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (19 papers), Metabolism, Diabetes, and Cancer (18 papers), Adipose Tissue and Metabolism (15 papers), Peroxisome Proliferator-Activated Receptors (13 papers), Diet, Metabolism, and Disease (12 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers), Genomics, phytochemicals, and oxidative stress (11 papers) and Parkinson's Disease Mechanisms and Treatments (10 papers). The work is most often cited by research in Pharmacology (451 citations), Molecular Biology (3.3k citations), Toxicology (154 citations), Endocrinology, Diabetes and Metabolism (702 citations) and Cancer Research (625 citations). Chul‐Ho Lee has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Don‐Kyu Kim, Jung‐Ran Noh, Yong‐Hoon Kim, Jung Hwan Hwang, Kyoung‐Shim Kim, Hueng-Sik Choi, Yong Deuk Kim, In‐Kyu Lee, Yong‐Hoon Kim and Gil‐Tae Gang. Their work appears in journals such as Journal of Biological Chemistry, Diabetes, Experimental & Molecular Medicine, Archives of Toxicology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.